{"id":"https://openalex.org/W4283169873","doi":"https://doi.org/10.1158/1538-7445.am2022-6343","title":"Abstract 6343: A multispecific T cell engager binding to both membrane proximal and membrane distal epitopes of MSLN with low affinity CD3 for the treatment of AML and solid tumors","display_name":"Abstract 6343: A multispecific T cell engager binding to both membrane proximal and membrane distal epitopes of MSLN with low affinity CD3 for the treatment of AML and solid tumors","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4283169873","doi":"https://doi.org/10.1158/1538-7445.am2022-6343"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-6343","doi":"https://doi.org/10.1158/1538-7445.am2022-6343","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6343","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005902696","display_name":"Cuiqing Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cuiqing Yang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiaohui Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaohui Shao","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101402214","display_name":"Feng Zhou","orcid":"https://orcid.org/0009-0007-3050-6239","observed_orcids":["https://orcid.org/0009-0007-3050-6239"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng Zhou","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lei Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Zhou","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062933960","display_name":"Qi Deng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qi Deng","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yun Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yun Zhang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014351234","display_name":"Guangcun Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guangcun Cheng","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101515292","display_name":"Yingying Hu","orcid":"https://orcid.org/0000-0002-3179-3977","observed_orcids":["https://orcid.org/0000-0002-3179-3977"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingying Hu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000152369","display_name":"Huaiyuan Ma","orcid":"https://orcid.org/0000-0002-4666-000X","observed_orcids":["https://orcid.org/0000-0002-4666-000X"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huaiyuan Ma","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044383055","display_name":"Yadan Wu","orcid":"https://orcid.org/0009-0004-3002-8810","observed_orcids":["https://orcid.org/0009-0004-3002-8810"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yadan Wu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shuai Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuai Wang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101849316","display_name":"Jie Zang","orcid":"https://orcid.org/0000-0003-2377-1097","observed_orcids":["https://orcid.org/0000-0003-2377-1097","https://orcid.org/0009-0002-8281-9177"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Zang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100349547","display_name":"Lei Liu","orcid":"https://orcid.org/0000-0002-3570-2219","observed_orcids":["https://orcid.org/0000-0002-3570-2219","https://orcid.org/0009-0000-0282-9144"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Liu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009616306","display_name":"Wenqing Yang","orcid":"https://orcid.org/0000-0002-4721-6197","observed_orcids":["https://orcid.org/0000-0002-4721-6197"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenqing Yang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yang Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102716803","display_name":"Chunlei Xia","orcid":"https://orcid.org/0000-0002-2138-7780","observed_orcids":["https://orcid.org/0000-0002-2138-7780"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunlei Xia","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101835363","display_name":"Jianzhong Hu","orcid":"https://orcid.org/0000-0002-0736-1488","observed_orcids":["https://orcid.org/0000-0002-0736-1488"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianzhong Hu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032685675","display_name":"Ande Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ande Luo","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033611704","display_name":"Yayuan Fu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yayuan Fu","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111796019","display_name":"Zhuoxiao Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhuoxiao Cao","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112841401","display_name":"Renhong Tang","orcid":"https://orcid.org/0009-0005-3494-707X","observed_orcids":["https://orcid.org/0009-0005-3494-707X","https://orcid.org/0000-0003-2560-8437"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Renhong Tang","raw_affiliation_strings":["1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Jiangsu Simcere Pharmaceutical Co. Ltd., Nanjing, Jiangsu, China, China","institution_ids":["https://openalex.org/I4210096870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210096870"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"6343","last_page":"6343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5795999765396118,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5795999765396118,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.14309999346733093,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.08720000088214874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/t-cell-engagers","display_name":"T-cell engagers","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.5839999914169312},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.824999988079071},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.984000027179718},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6240000128746033},{"id":"https://openalex.org/keywords/ca125","display_name":"CA125","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.902099072933197},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6141653060913086},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5284920930862427},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4685042202472687},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.465145468711853},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45362016558647156},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4159787893295288},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41494494676589966},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32873862981796265},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28045257925987244},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23177433013916016},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10761049389839172}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-6343","doi":"https://doi.org/10.1158/1538-7445.am2022-6343","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6343","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3099545979","https://openalex.org/W4384030807","https://openalex.org/W2891236977","https://openalex.org/W3109867671","https://openalex.org/W7162812610","https://openalex.org/W2886763828","https://openalex.org/W4362592213","https://openalex.org/W4417116772","https://openalex.org/W4308377704","https://openalex.org/W4388083093"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"The":[2],"effective":[3],"treatment":[4,477],"of":[5,26,50,125,150,170,205,212,243,332,366,393,469,478,486],"AML":[6,29,406,479],"and":[7,30,44,96,118,147,156,168,178,198,209,238,248,269,306,323,400,407,465,480],"solid":[8,31,409,481],"tumors":[9,482],"remains":[10],"an":[11],"unmet":[12],"medical":[13],"need.":[14],"Mesothelin":[15],"(MSLN)":[16],"is":[17,291,308],"a":[18,24,60,134,188,229,276,346],"glycophosphatidylinositol-linked":[19],"tumor":[20,270,343],"antigen":[21],"overexpressed":[22],"in":[23,88,110,172,173,179,187,246,249,262,265,337,345,364,369,405],"variety":[25],"malignancies,":[27],"including":[28],"tumors,":[32],"such":[33],"as":[34,59,273],"mesothelioma,":[35],"cholangiocarcinoma,":[36],"ovarian,":[37],"pancreatic,":[38],"lung,":[39],"esophageal,":[40],"gastric,":[41],"colorectal,":[42],"endometrial":[43],"triple-negative":[45],"breast":[46],"cancer.":[47],"Early":[48],"signs":[49],"clinical":[51,403],"efficacy":[52,70,124,353,378,404],"with":[53,68,83,195,328,471],"MSLN-targeting":[54],"agents":[55],"have":[56],"validated":[57],"MSLN":[58,117,208,256,281,305,322,470],"promising":[61,240],"target":[62],"for":[63,103,293,475,490],"therapeutic":[64,81,391],"intervention,":[65],"but":[66],"therapies":[67],"improved":[69],"are":[71,78],"still":[72],"needed.":[73],"CD3-based":[74,106],"T":[75,84,97,107,126,154,257,266,288,384,398,457],"cell":[76,85,98,108,127,258,267,271,289,385,458],"engagers":[77,109],"highly":[79],"potent":[80],"molecules":[82],"cytotoxicity":[86,189],"activities":[87],"the":[89,165,236,239,254,294,299,329,390,402,476,487],"picomolar":[90],"range.":[91],"But":[92],"high":[93,104,115,280],"CRS":[94],"risk":[95],"exhaustion":[99,290],"has":[100,260],"been":[101],"observed":[102],"affinity":[105,116,120,473],"clinicals,":[111],"so":[112],"we":[113,234,317,335],"used":[114],"low":[119,472],"CD3":[121,301,351,474],"to":[122,142,157,163,216,275,298,396,461],"improve":[123,401],"engager.":[128,386],"Experimental":[129],"Design:":[130],"We":[131,251,284],"designed":[132],"SMTE-001,":[133],"78-kDa,":[135],"tetra-specific,":[136],"T-cell-activating":[137],"protein":[138],"molecule,":[139],"which":[140,201],"binds":[141],"two":[143],"epitopes":[144,468],"(membrane":[145],"proximal":[146,464],"membrane":[148,463,466],"distal)":[149],"MSLN,":[151],"CD3\u03b5":[152],"on":[153,219,279],"cells,":[155,200],"serum":[158],"albumin.":[159],"Experiments":[160],"were":[161,226],"conducted":[162,227],"assess":[164],"potency,":[166],"activity,":[167],"half-life":[169],"HPN536":[171],"vitro":[174,247,263],"assays,":[175],"rodent":[176],"models,":[177],"nonhuman":[180],"primates":[181],"(NHP).":[182],"This":[183],"molecule":[184,245,395],"was":[185,214],"tested":[186],"assay":[190],"using":[191,228],"human":[192],"PBMCs":[193],"co-cultured":[194],"OVCAR3,":[196],"Hela":[197],"NCI-H292":[199],"express":[202],"different":[203],"levels":[204],"MSLN.":[206],"Soluble":[207],"CA125":[210,307,324],"(ligand":[211],"MSLN)":[213],"added":[215],"determine":[217],"effects":[218],"cytotoxicity.":[220],"In":[221,358],"vivo":[222,338],"xenograft":[223],"mouse":[224],"studies":[225],"PBMC":[230],"model.":[231],"Results:":[232],"Here":[233],"report":[235],"design":[237],"preclinical":[241],"activity":[242,331],"SMTE-001":[244,340,361],"vivo.":[250],"demonstrate":[252,286,319,336,375],"that":[253,287,320,339],"bivalent":[255,383],"engager":[259,459],"increased":[261],"potency":[264],"activation":[268],"killing,":[272],"compared":[274,297],"monovalent":[277],"counterpart":[278],"expressing":[282],"cells.":[283],"also":[285,318],"reduced":[292],"low-affinity":[295,300],"CD3,":[296],"molecule.":[302],"Because":[303],"soluble":[304,321],"shed":[309],"from":[310],"cancer":[311,314],"cells":[312,399],"into":[313],"patient":[315],"serum,":[316],"does":[325],"not":[326],"interfere":[327],"cytotoxic":[330],"SMTE-001.":[333],"Importantly,":[334],"significantly":[341],"inhibits":[342],"growth":[344],"dose-dependent":[347],"manner,":[348],"while":[349],"high-affinity":[350],"molecule\u2019":[352],"reduces":[354],"when":[355],"higher":[356],"dosing.":[357],"cynomolgus":[359],"monkeys,":[360],"shows":[362],"pharmacokinetics":[363],"support":[365],"weekly":[367],"dosing":[368],"humans.":[370],"Conclusions:":[371],"Collectively,":[372],"these":[373],"data":[374,388],"strong":[376],"anti-tumor":[377],"by":[379],"this":[380,394],"novel":[381],"multispecific":[382,456],"These":[387],"indicate":[389],"potential":[392],"activate":[397],"MSLN-expressing":[408],"tumors.":[410],"Citation":[411],"Format:":[412],"Cuiqing":[413],"Yang,":[414,440],"Xiaohui":[415],"Shao,":[416],"Feng":[417],"Zhou,":[418,420],"Lei":[419,437],"Qi":[421],"Deng,":[422],"Yun":[423],"Zhang,":[424],"Guangcun":[425],"Cheng,":[426],"Yingying":[427],"Hu,":[428,446],"Huaiyuan":[429],"Ma,":[430],"Yadan":[431],"Wu,":[432],"Shuai":[433],"Wang,":[434],"Jie":[435],"Zang,":[436],"Liu,":[438,442],"Wenqing":[439],"Yang":[441],"Chunlei":[443],"Xia,":[444],"Jianzhong":[445],"Ande":[447],"Luo,":[448],"Yayuan":[449],"Fu,":[450],"Zhuoxiao":[451],"Cao,":[452],"Renhong":[453],"Tang.":[454],"A":[455],"binding":[460],"both":[462],"distal":[467],"[abstract].":[483],"In:":[484],"Proceedings":[485],"American":[488],"Association":[489],"Cancer":[491,502],"Research":[492],"Annual":[493],"Meeting":[494],"2022;":[495],"2022":[496],"Apr":[497],"8-13.":[498],"Philadelphia":[499],"(PA):":[500],"AACR;":[501],"Res":[503],"2022;82(12_Suppl):Abstract":[504],"nr":[505],"6343.":[506]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-06-21T00:00:00"}